Robert Glass
Alphacentric Advisors Llc
Assets Managed
$100.111M
Holdings
252
Last Quarter
2026 - Q1
Filed Date
9d ago
Growth Rate
-0.23%(2Q avg: -0.05%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Alphacentric Advisors Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 252 positions.
Assets under management
The assets under management (AUM) of Alphacentric Advisors Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 100.111M in assets, with a quarterly growth rate of -0.23% and a 2-quarter average growth rate of -0.05%. The portfolio is managed by Robert Glass, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
GILD Gilead Sciences Inc
| 2.83% | $2.824M 20,260 shares@ $139.37 avg price | Decreased -6.89% |
RPV Invesco S&p 500 Pure Value E
| 2.57% | $2.565M 23,882 shares@ $107.4 avg price | Increased 38.78% |
IWD Ishares Russell 1000 Value E
| 2.53% | $2.527M 11,825 shares@ $213.68 avg price | Increased 40.66% |
AZNCF Astrazeneca Plc
| 2.22% | $2.215M 11,232 shares@ $197.22 avg price | New Position |
VRTX Vertex Pharmaceuticals Inc
| 2.2% | $2.202M 4,931 shares@ $446.55 avg price | Increased 5.75% |
EEFT Euronet Worldwide Inc
| 1.85% | $1.849M 27,855 shares@ $66.37 avg price | |
INVH Invitation Homes Inc
| 1.82% | $1.814M 73,000 shares@ $24.85 avg price | Decreased -18.88% |
IONS Ionis Pharmaceuticals Inc
| 1.47% | $1.471M 19,587 shares@ $75.1 avg price | Increased 5.75% |
INSM Insmed Inc
| 1.45% | $1.451M 8,874 shares@ $163.52 avg price | Increased 16.95% |
INCY Incyte Corp
| 1.34% | $1.341M 14,245 shares@ $94.12 avg price | Increased 5.75% |
1-10 of 252